Pfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for people 65 and older, a group for which the agency has previously been quick to approve new shots, the Washington Post reported.
Subscribe to:
Post Comments (Atom)
< + > Beyond Data Exchange: The Next Era of Interoperability Happens Inside Clinical Workflows
The following is a guest article by Jonathan Shoemaker , CEO at ABOUT Healthcare For a time period that seems like just about forever, the ...
No comments:
Post a Comment